Structure Therapeutics Inc.
GPCR
$21.76
$3.2317.43%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 51.24% | 77.81% | 98.80% | 103.53% | 99.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.96% | 67.77% | 71.80% | 94.30% | 95.53% |
| Operating Income | -53.96% | -67.77% | -71.80% | -94.30% | -95.53% |
| Income Before Tax | -36.73% | -44.46% | -53.04% | -73.28% | -74.22% |
| Income Tax Expenses | 31.36% | -137.50% | 386.11% | 1,433.33% | 1,288.24% |
| Earnings from Continuing Operations | -36.72% | -43.59% | -53.23% | -73.76% | -74.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.72% | -43.59% | -53.23% | -73.76% | -74.63% |
| EBIT | -53.96% | -67.77% | -71.80% | -94.30% | -95.53% |
| EBITDA | -53.46% | -67.39% | -71.63% | -94.42% | -95.97% |
| EPS Basic | 7.81% | 60.04% | 74.32% | 82.19% | 84.86% |
| Normalized Basic EPS | 13.70% | 60.78% | 75.00% | 82.03% | 84.82% |
| EPS Diluted | 7.81% | 60.04% | 74.32% | 82.19% | 84.86% |
| Normalized Diluted EPS | 13.70% | 60.78% | 75.00% | 82.03% | 84.82% |
| Average Basic Shares Outstanding | 43.41% | 92.20% | 162.72% | 403.73% | 1,048.74% |
| Average Diluted Shares Outstanding | 43.41% | 92.20% | 162.72% | 403.73% | 1,048.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |